Silvia E. Jiménez

发表

Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica.

D. Lowy, S. Wacholder, W. Quint, 2013, The Journal of infectious diseases.

Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)

D. Morgan, G. Anderson, C. Porras, 2013, Cancer Causes & Control.

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

D. Lowy, S. Wacholder, W. Quint, 2013, PloS one.

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

D. Lowy, S. Wacholder, D. Solomon, 2007, JAMA.

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.

Diane Solomon, John Schiller, Allan Hildesheim, 2008, Vaccine.

Evaluation of the FTA Carrier Device for Human Papillomavirus Testing in Developing Countries

W. Quint, A. Hildesheim, A. Rodriguez, 2012, Journal of Clinical Microbiology.

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

D. Lowy, S. Wacholder, J. Palefsky, 2022, Nature Communications.

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.

Diane Solomon, Wim Quint, Allan Hildesheim, 2011, Cancer discovery.

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.

D. Lowy, S. Wacholder, W. Quint, 2011, The Lancet. Oncology.

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

D. Lowy, S. Wacholder, M. Sherman, 2011, Journal of the National Cancer Institute.

Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT).

D. Lowy, S. Wacholder, M. Sherman, 2020, The Journal of infectious diseases.

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes

D. Lowy, M. Yeager, S. Wacholder, 2019, The Journal of infectious diseases.

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.

D. Lowy, S. Wacholder, W. Quint, 2016, Journal of the National Cancer Institute.

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

S. Chanock, M. Gail, D. Lowy, 2018, Vaccine.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

D. Lowy, C. Wheeler, S. Wacholder, 2015, The Lancet. Oncology.

Seroprevalence and Correlates of Human Papillomavirus 16/18 Seropositivity Among Young Women in Costa Rica

S. Wacholder, M. Sherman, W. Quint, 2010, Sexually transmitted diseases.

Determinants of seropositivity among HPV-16/18 DNA positive young women

S. Wacholder, M. Sherman, M. Schiffman, 2010, BMC infectious diseases.

Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica.

D. Lowy, S. Wacholder, W. Quint, 2012, The Journal of infectious diseases.

Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing.

S. Wacholder, W. Quint, A. Hildesheim, 2014, Journal of the National Cancer Institute.

Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods

Allan Hildesheim, Patti E. Gravitt, Hormuzd A. Katki, 2008, Journal of Clinical Microbiology.

Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure

L. Dodd, S. Wacholder, M. Sherman, 2011, Sexually transmitted diseases.

Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment.

S. Wacholder, D. Solomon, A. Hildesheim, 2013, American Journal of Epidemiology.

Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.

D. Lowy, S. Wacholder, W. Quint, 2014, The Journal of infectious diseases.

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.

D. Lowy, S. Wacholder, J. Palefsky, 2015, Vaccine.

Establishment and Operation of a Biorepository for Molecular Epidemiologic Studies in Costa Rica

A. Hildesheim, A. Rodriguez, M. Schiffman, 2010, Cancer Epidemiology, Biomarkers & Prevention.